Clinical Trial

Ketamine and Propofol NeuroImaging

Study acronym: KAPNI
Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This is a multi-visit which will collect MRI (pictures of the brain) and EEG (brain waves) data to determine changes in brain connectivity and brain activity for memory formation and pain perception while receiving the commonly-used anesthetic agents ketamine and propofol, both alone and in combination.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-12-17; most recent amendment 2026-05-15.
Trial Details
NCT Number NCT07294092
Lead Sponsor Keith M Vogt
Collaborators: National Institute of General Medical Sciences (NIGMS)
Conditions Anesthesia, Pain
Enrollment 60 participants
Start Date 2026-04-10
Primary Completion 2028-08-01 (estimated)
Study Completion 2028-08-02 (estimated)
Updated on ClinicalTrials.gov 2026-05-19